Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

Fig. 3

Time courses of the change in (a) fasting plasma glucose (FPG) and (b) body weight from the baseline. Each point and bar represents the LS mean ± SE. *p < 0.001 vs placebo by ANCOVA. The number of patients at each point is shown in the lower table. N number of patients at each point, 16 (LOCF) last observation carried forward to week 16

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840